Apis Partners Announces Final Close of $1.23 Billion Fund III, Double its Predecessor
7.5.2026 09:00:00 EEST | Business Wire | Press release
Apis Partners Group (UK) Limited (“Apis”), a private equity firm investing in tech-enabled businesses in financial infrastructure and services, today announced the final close of Apis Global Growth Fund III and Apis Growth Markets Fund III (the “Funds” or “Fund III”), with combined commitments of $1.23 billion excluding co-investments, more than double its predecessor, Apis Growth Fund II, at $563 million.
The Funds closed 23% above target.Reflecting the strong performance of previous funds,which have already generated in excess of $1 billion in realisations to date, over 70% of existing LPs have re-upped and increased on their previous fund’s commitments, accounting for around 50% of the total capital raised in Fund III. The significant increase in fund size allowed Apis to welcome a number of new investors to its global institutional investor base, including sovereign and supranational investors alongside banks, insurers, pension funds, funds of funds and foundations.
Fund III will build on the strength of Fund II to invest meaningful minority stakes in high growth, profitable financial infrastructure and services businesses in Europe and select growth markets globally. An active deployer of capital in the sector, Apis has invested approximately $400 million from Fund III across seven investments to date. These include MoneyBox, a leader in the UK digital wealth management space, Coda Recharge, a leading European and Asian platform for prepaid digital goods, and Thunes, a global provider of cutting-edge digital payments infrastructure enabling instant cross-border money transfers, payment acceptance, and acquiring services headquartered in Singapore.
Matteo Stefanel, Apis Co-Founder and Managing Partner said: “We are delighted to welcome so many new and returning investors into Fund III. We continue to see opportunities in our target segment of profitable, high growth, tech-enabled financial infrastructure and services companies. We are well on our way to replicating the success of previous funds, by leveraging our experience in this sector and bringing capital and connectivity to our portfolio companies as we invest in the conduits to global economic activity, the pipes of the finance industry.”
Udayan Goyal, Apis Co-Founder and Managing Partner added: “We are incredibly grateful to our investors for their strong support of our sector-focused strategy, validating our belief that specialist funds outperform generalist funds. We look forward to continuing to invest in our key themes of embedded finance, democratisation of finance and the deepening of the digital economy through capital-light, high growth disruptive business models around the world whilst applying our proprietary impact methodology.”
The close of Fund III marks an active 12 months including three investments and realisations including exiting iKhokha and Baobab to Nedbank and Beltone Capital respectively. Apis was the highest ranked European private equity firm in HEC Dow-Jones’ 2025 growth capital private equity performance ranking and second globally, underscoring its consistent outperformance in delivering strong returns to investors.
Notes to Editors
Headquartered in London, Apis Partners (“The Firm”) is a private equity firm investing in tech-enabled financial infrastructure and services across Europe and growth markets, with US$2.3 billion AUM. The Firm invests in profitable, proven business models, partnering with management teams to support long-term growth and value creation.
For over a decade, we have invested in businesses across payments, insurance, and lending, that are the conduits through which the global economy flows. These businesses sit within regulatory and operational frameworks, and are attractive to strategic acquirers globally.
With over 40 professionals across three locations in London, Dubai and Singapore, responsible investment is embedded in how we operate, with ESG and impact considerations fully integrated throughout our investment process
Apis was the highest-ranked financial sector-focused firm and #2 globally in the 2025 HEC Paris-Dow Jones Growth Equity Investor Ranking.
LinkedIn: https://www.linkedin.com/company/apis-partners/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260506645124/en/
Contacts
Media Contacts
Global
Stephanie Mullard | stephanie.mullard@apis.pe | +44 7377 952886
Camarco | apis@camarco.co.uk | +44 7972 013 692
Middle East
APCO Worldwide
Georgine Whittle | gwhittle@apcoworldwide.com | +971 52 762 5998
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MOVIVA ® launch spotlight at ESGE Days 20267.5.2026 10:58:00 EEST | Press release
During its 175th anniversary year, Erbe Elektromedizin GmbH highlights its continued commitment to healthcare innovation with the launch of MOVIVA®, a minimally invasive solution for gastric mucosal ablation (GMA) in endoscopic obesity therapy. MOVIVA® will be the central focus of Erbe’s activities at ESGE Days in Milan, 14–16 May 2026. Physicians can explore the technology in the hands-on area and attend a dedicated symposium. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507842222/en/ How GMA with MOVIVA® works “Obesity continues to rise worldwide, and many patients still face a gap between lifestyle interventions, pharmacotherapy, and bariatric surgery. Endoscopic approaches are emerging as additional treatment options. With MOVIVA®, we aim to support physicians in bringing this innovative treatment option into clinical practice and expanding access to minimally invasive obesity therapies.” Marcus Felstead, Chief Comm
Resilience Takes Center Stage as Europe’s LEED Community Gathers in Milan for GBCI Europe Circle 20267.5.2026 10:57:00 EEST | Press release
Green Business Certification Inc. Europe (GBCI), is hosting Circle 2026, the annual flagship event of the European LEED community, taking place in Milan from May 6–8 and marking its fifth anniversary. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506692329/en/ Porta Nuova, Milan - LEED v4.1 Communities: Existing, Gold certification. Photo courtesy of COIMA. At the center of discussions is LEED v5, the latest version of the world’s most widely used green building rating system, as a bridge to EU Taxonomy alignment - a critical priority for the European market, where regulatory pressure and investor demand are accelerating the integration of certification, finance, and ESG reporting. GBCI Europe Impact Report 2026: European Real Estate Shifts from Sustainability to Risk Management As part of the main conference program, Peter Templeton, President and CEO of USGBC and GBCI will present the GBCI Europe Impact Report 2026, ba
Criteo Selects Navan to Modernize Global Travel Management7.5.2026 10:00:00 EEST | Press release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507251188/en/ Global commerce intelligence platform delivers high employee satisfaction with Navan Criteo set out to provide its global workforce with an easy-to-use travel booking experience that brought visibility and control to its travel spending. Prioritizing operational excellence and employee experience, Criteo selected Navan because of its extensive inventory, unified travel and payments platform, and global expertise in sustainability reporting. “We wanted to give our teams a travel tool that’s as easy to use as the apps they use in their personal lives,” said Sarah Glickman, Chief Financial Officer at Criteo. “Our goal with Navan was to improve the use
LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery7.5.2026 10:00:00 EEST | Press release
LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506065669/en/ Bernard Blerot, VP R&D Naturals at IFF, smelling geranium in a botanical research laboratory. “Responsible innovation has always been central to LMR,” said Bertrand de Préville, general manager of LMR. “Our strength lies in our ability to master the full range of natural technologies to support perfumers’ creativity. We’re connecting nature, science and creation to drive sustainable growth and deliver added value to our customers at global scale.” Four New LMR Hearts Introduced at SIMPPAR LMR
Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 20267.5.2026 08:13:00 EEST | Press release
A path breaking scientific discovery, unraveling successful wound healing mechanism in urethral stricture with BEES-HAUS cell therapy has been reported by Indo-Japan physician-scientists. This milestone achievement in regenerative medicine, yielding clinical safety and efficacy, is the first of its kind, wherein a hybrid approach of mixing two groups of autologous buccal epithelial cells,one cultured in 2D and another in 3D in Festigel scaffold were used in the management of urethral stricture; paracrine effect of IGF-1 produced by 2D-cultured cells and engraftment of 3D-Festigel cultured cells, which cover the urethrotomy wound, together repairing the urothelial defect, has been published in Frontiers in Urology. This feat though modest, is a global first in terms of both in vitro tissue engineering and clinical benefits by in vivo healing, restoring the urothelial integrity and is a giant leap for its potential of yielding stricture recurrence-free good quality of life to patients wi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom